Danièl Thomas

7.5k total citations · 1 hit paper
117 papers, 4.0k citations indexed

About

Danièl Thomas is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, Danièl Thomas has authored 117 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 30 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Danièl Thomas's work include Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Danièl Thomas is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Danièl Thomas collaborates with scholars based in United States, Australia and India. Danièl Thomas's co-authors include Ravindra Majeti, Angel F. López, Mark A. Guthridge, Steven M. Chan, M. Ryan Corces, Frank Sinatra, Wan‐Jen Hong, Russell J. Merritt, Feifei Zhao and Andreas Reinisch and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Danièl Thomas

111 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia

2015 418 citations Steven M. Chan, Danièl Thomas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danièl Thomas United States	31	1.8k	1.4k	857	790	546	117	4.0k
C. Arnold Spek Netherlands	41	1.7k 1.0×	1.5k 1.1×	946 1.1×	609 0.8×	485 0.9×	165	5.1k
Neal D. Tolley United States	23	1.5k 0.9×	1.6k 1.1×	929 1.1×	633 0.8×	606 1.1×	35	4.3k
Yasuhito Nannya Japan	33	1.4k 0.8×	1.3k 0.9×	479 0.6×	585 0.7×	449 0.8×	219	3.9k
Henrik Sengeløv Denmark	36	1.9k 1.1×	1.4k 1.0×	2.2k 2.6×	787 1.0×	473 0.9×	149	6.2k
Luca Pierelli Italy	34	1.2k 0.7×	1.2k 0.9×	1.2k 1.4×	1.3k 1.7×	225 0.4×	171	4.1k
P. Sève France	44	1.5k 0.9×	1.1k 0.8×	1.0k 1.2×	1.2k 1.5×	326 0.6×	280	6.9k
Akio Urabe Japan	34	1.1k 0.6×	1.5k 1.1×	1.3k 1.5×	1.1k 1.5×	262 0.5×	163	4.7k
Rami Mahfouz Lebanon	29	1.2k 0.7×	1.0k 0.7×	457 0.5×	533 0.7×	335 0.6×	200	3.5k
Günther Gastl Austria	38	1.2k 0.7×	959 0.7×	1.2k 1.4×	1.3k 1.6×	372 0.7×	137	4.3k
Nancy Berliner United States	42	1.6k 0.9×	2.7k 1.9×	2.4k 2.8×	732 0.9×	298 0.5×	141	5.7k

Countries citing papers authored by Danièl Thomas

Since Specialization

Citations

This map shows the geographic impact of Danièl Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danièl Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danièl Thomas more than expected).

Fields of papers citing papers by Danièl Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danièl Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danièl Thomas. The network helps show where Danièl Thomas may publish in the future.

Co-authorship network of co-authors of Danièl Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Danièl Thomas. A scholar is included among the top collaborators of Danièl Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danièl Thomas. Danièl Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiseman, Thomas, Deepak Singhal, David T Yeung, et al.. (2024). Higher Rate of Red Blood Cell (RBC) Alloimmunization in RBC-Transfused Myelodysplastic Syndrome Compared to Acute Myeloid Leukemia. Blood. 144(Supplement 1). 1267–1267.

Robinson, Nirmal, Monika Kutyna, Kelly Lim, et al.. (2024). High Dose Ascorbate Reduces Interleukin-1 Beta Secretion in TET2 Mutant Monocytes and Demonstrates Excellent Safety and Tolerability in CMML Patients in Combination with Azacitidine. Blood. 144(Supplement 1). 1817–1817. 2 indexed citations

Hiwase, Devendra, David M. Ross, David T Yeung, et al.. (2024). Durable Responses Observed in Chronic Myelomonocytic Leukemia Treated with Lenzilumab and Azacitidine. Blood. 144(Supplement 1). 1006–1006. 2 indexed citations

Lim, Kelly, Winnie L. Kan, Pramod C. Nair, et al.. (2024). CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting. PLoS ONE. 19(9). e0310641–e0310641.

Nair, Pramod C., Jacob Piehler, Denis Tvorogov, et al.. (2023). Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches. Blood Cancer Discovery. 4(5). 352–364. 12 indexed citations

Landberg, Niklas, Thomas Köhnke, Yang Feng, et al.. (2023). IDH1 -Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation. Blood Cancer Discovery. 5(2). 114–131. 9 indexed citations

Sconocchia, Tommaso, Karl Kashofer, Christine Beham‐Schmid, et al.. (2023). Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia. 37(4). 843–853. 8 indexed citations

Thomas, Danièl, Manhong Wu, Yusuke Nakauchi, et al.. (2022). Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability. Cancer Discovery. 13(2). 496–515. 39 indexed citations

Kutyna, Monika, Chung Hoow Kok, Yoon Lim, et al.. (2022). A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure. Leukemia. 36(11). 2678–2689. 15 indexed citations

10.

Azizi, Armon, et al.. (2021). Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia. Nature Communications. 12(1). 7244–7244. 36 indexed citations

11.

Tvorogov, Denis, Danièl Thomas, Nicholas P. D. Liau, et al.. (2018). Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosis. Science Advances. 4(11). eaat3834–eaat3834. 41 indexed citations

12.

Reinisch, Andreas, Steven M. Chan, Danièl Thomas, & Ravindra Majeti. (2015). Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells. Seminars in Hematology. 52(3). 150–164. 48 indexed citations

13.

George, Amee J., Brooke W. Purdue, Cathryn M. Gould, et al.. (2013). A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation. Journal of Cell Science. 126(Pt 23). 5377–90. 32 indexed citations

14.

Roberts, Kathryn G., Amanda M. Smith, Fiona McDougall, et al.. (2010). Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers. Cancer Research. 70(13). 5438–5447. 100 indexed citations

15.

Thomas, Danièl, Mathew A. Vadas, & Angel F. López. (2004). Regulation of haematopoiesis by growth factors – emerging insights and therapies. Expert Opinion on Biological Therapy. 4(6). 869–879. 17 indexed citations

16.

Seidman, Ernest G., Neal S. LeLeiko, Marvin E. Ament, et al.. (1991). Nutritional Issues in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 12(4). 424–448. 84 indexed citations

17.

Roe, Thomas F., Danièl Thomas, Vicente Gilsanz, Hart Isaacs, & James B. Atkinson. (1986). Inflammatory bowel disease in glycogen storage disease type Ib. The Journal of Pediatrics. 109(1). 55–59. 58 indexed citations

18.

Tong, Myron J., et al.. (1984). Need for immunoprophylaxis in infants born to HBsAg-positive carrier mothers who are HBeAg negative. The Journal of Pediatrics. 105(6). 945–947. 23 indexed citations

19.

Merritt, Russell J., et al.. (1981). Lactic acidosis in pediatric patients with cancer receiving total parenteral nutrition. The Journal of Pediatrics. 99(2). 247–250. 6 indexed citations

20.

Thomas, Danièl. (1952). Left-sided Appendicitis. BMJ. 2(4774). 43.2–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact